Long Description

Silodosin 8 mg + Dutasteride IP 0.5 mg is a combination pharmaceutical formulation developed for the effective management of benign prostatic hyperplasia (BPH) under medical supervision. The formulation combines two complementary active ingredients that work together to help relieve urinary symptoms associated with an enlarged prostate gland and support improved urinary flow and bladder function.

Benign prostatic hyperplasia is a common condition in aging men that can lead to urinary difficulties such as weak urine flow, frequent urination, difficulty starting urination, nighttime urination, and incomplete bladder emptying. This combination therapy is designed to address both the symptoms and underlying causes of prostate enlargement, providing comprehensive support for long-term prostate health management.

Silodosin is an alpha-blocker that works by relaxing the muscles in the prostate and bladder neck, helping improve urine flow and reduce urinary discomfort. Its targeted action helps relieve symptoms associated with urinary obstruction and improves overall urinary function.

Dutasteride works by inhibiting the conversion of testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate enlargement. By lowering DHT levels, Dutasteride helps reduce prostate size over time and supports long-term management of BPH symptoms.

The combination of Silodosin and Dutasteride provides a dual-action approach by offering both rapid symptomatic relief and long-term prostate size management. This helps improve urinary comfort, reduce urinary retention risk, and enhance overall quality of life for patients undergoing treatment.

Manufactured under strict WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical processes and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and pharmaceutical excellence.

Key Features

• Dual-action formulation for BPH management
• Helps improve urinary flow and bladder function
• Supports long-term prostate health management
• Helps reduce symptoms of enlarged prostate
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes

Uses

• Benign prostatic hyperplasia (BPH) management
• Urinary flow improvement support
• Relief from enlarged prostate symptoms
• Long-term prostate health support under medical supervision

Storage Instructions

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.